Nanoscale materials and devices hold great promise for advanced diagnostics, sensors, targeted drug delivery, smart drugs, screening and novel cellular therapies. The Nanotechnology Program at CMIR develops, optimizes and validates creative approaches to diagnosis and treatment of human disorders. The Nanotechnology Program at CMIR is funded through two NIH designated Centers of Excellence:
Translation Program of Excellence in Nanotechnology (TPEN; U01-HL080731) funded through the National Heart Lung and Blood Institute (NHLBI).
Center of Cancer Nanotechnology Excellence (CCNE; U54-CA119349) funded through the National Cancer Institute (NCI)
Both programs are multidisciplinary and interinstitutional involving investigators from Harvard University, Harvard Medical School, Harvard affiliated teaching hospitals, the Broad Institute and MIT."